All
Screening labs, complacency, and the ABCDEs of pediatric melanoma
August 11th 2015In part three of our discussion about pediatric dermatology, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses screening labs, avoiding complacency, and the ABCDEs of melanoma with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
Antibiotic-free treatment effective, safe for moderate-to-severe acne
July 20th 2015“The increased strength of adapalene (a retinoid) is a valuable ingredient to explore in view of the growing incidence of drug resistance and the fact that it apparently worked in moderate to severe acne patients is a very good sign," says an expert. Learn more.
Technology advances cellulite treatment
July 16th 2015We finally have effective interventions that address the root cause of cellulite (fibrous tethers). Now, patient education and selection becomes paramount. Long horizontal lines and the infragluteal cleft or bulge, the so-called “banana-roll” cannot be corrected with these interventions. Prior to performing cellulite procedures we must impart this knowledge to our patients to ensure realistic expectations.
Protecting inventions is complex, costly, crucial
July 14th 2015Securing a patent requires time, money and a thorough understanding of where your product fits among existing intellectual property, experts say. Other tools for protecting intellectual property include copyrights, trademarks and proprietary information and processes.
Pediatric psoriasis, eczema: Triggers and therapies
July 10th 2015In part two of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses environmental and microbial triggers and when to choose systemic therapies with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
Evidence-based guidance for psoriasis treatment
July 9th 2015Newer therapies to treat psoriasis and psoriatic arthritis are more likely to be successful in patients with no prior exposure to biologics. Traditional therapies remain an option but, unlike newer treatments, require monitoring for toxicities.
QUIZ: Tender nodules covering scalp. What’s Your Diagnosis?
July 7th 2015A 48 year old man presents with a 2 year history of painful, disseminated, tender nodules covering his scalp. Many lesions are inflammatory with purulent discharge, and alopecia is noted over nodules. The patient reports clinical worsening after mental and physical stress. He has been treated with oral antibiotics, such as clindamycin hydrochloride and erythromycin, with poor response.
Rapid responders may offer clues to optimize immune therapy
July 6th 2015Some patients respond more rapidly to immune therapies like ipilimumab, and clinicians have observed delayed toxicities with prolonged use of checkpoint inhibitors; effective treatments for subtypes of melanoma, such as uveal melanoma, have not yet emerged.